1-6 of 6
Andrew R. Green
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ

Karuna Mittal, Michael S. Toss, Guanhao Wei, Jaspreet Kaur, Da Hoon Choi, Brian D. Melton, Remus M. Osan, Islam M. Miligy, Andrew R. Green, Emiel A.M. Janssen, Håvard Søiland, Keerthi Gogineni, Upender Manne, Padmashree Rida, Emad A. Rakha, Ritu Aneja
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (12): 2898–2907.
https://doi.org/10.1158/1078-0432.CCR-19-1272
Published: 15 June 2020
View article titled, A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma <em>In Situ</em>
Open the PDF for A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma <em>In Situ</em> in another window
Includes: Supplementary data
Journal Articles

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer

Chun Gong, Ellen P.S. Man, Ho Tsoi, Terence K.W. Lee, Paul Lee, Sai-Ting Ma, Lai-San Wong, Mai-Yee Luk, Emad A. Rakha, Andrew R. Green, Ian O. Ellis, Eric W.-F. Lam, Kwok-Leung Cheung, Ui-Soon Khoo
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15): 3681–3691.
https://doi.org/10.1158/1078-0432.CCR-17-2259
Published: 31 July 2018
View article titled, BQ323636.1, a Novel Splice Variant to <em>NCOR</em>2, as a Predictor for Tamoxifen-Resistant Breast Cancer
Open the PDF for BQ323636.1, a Novel Splice Variant to <em>NCOR</em>2, as a Predictor for Tamoxifen-Resistant Breast Cancer in another window
Includes: Supplementary data
Journal Articles

HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis

Tarek M.A. Abdel-Fatah, Stephanie E.B. McArdle, Devika Agarwal, Paul M. Moseley, Andrew R. Green, Graham R. Ball, A. Graham Pockley, Ian O. Ellis, Robert C. Rees, Stephen Y.T. Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (4): 905–914.
https://doi.org/10.1158/1078-0432.CCR-15-0610
Published: 14 February 2016
View article titled, HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis
Open the PDF for HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis in another window
Includes: Supplementary data
Journal Articles

Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes

Emad A. Rakha, Somaia E. Elsheikh, Muhammed A. Aleskandarany, Hany O. Habashi, Andrew R. Green, Desmond G. Powe, Maysa E. El-Sayed, Ahmed Benhasouna, Jean-Sébastien Brunet, Lars A. Akslen, Andy J. Evans, Roger Blamey, Jorge S. Reis-Filho, William D. Foulkes, Ian O. Ellis
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2302–2310.
https://doi.org/10.1158/1078-0432.CCR-08-2132
Published: 01 April 2009
View article titled, Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Open the PDF for Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes in another window
Journal Articles

Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification

Lucy R. Webster, Shu-Fen Lee, Clare Ringland, Adrienne L. Morey, Andrew M. Hanby, Graeme Morgan, Karen Byth, Patricia A. Mote, Pamela J. Provan, Ian O. Ellis, Andrew R. Green, Gillian Lamoury, Peter Ravdin, Christine L. Clarke, Robyn L. Ward, Rosemary L. Balleine, Nicholas J. Hawkins
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6625–6633.
https://doi.org/10.1158/1078-0432.CCR-08-0701
Published: 16 October 2008
View article titled, Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification
Open the PDF for Poor-Prognosis Estrogen Receptor–Positive Breast Cancer Identified by Histopathologic Subclassification in another window
Includes: Supplementary data
Journal Articles

Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients

Abeer M. Shaaban, Andrew R. Green, Suchita Karthik, Yalda Alizadeh, Thomas A. Hughes, Lynn Harkins, Ian O. Ellis, John F. Robertson, Emma C. Paish, Philippa T.K. Saunders, Nigel P. Groome, Valerie Speirs
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5228–5235.
https://doi.org/10.1158/1078-0432.CCR-07-4528
Published: 12 August 2008
View article titled, Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
Open the PDF for Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients in another window
Includes: Supplementary data